Medical Device Gastrointestinal Stents Market | Page 3

REPORT DESCRIPTION
Gastrointestinal Stents Market Dynamics:
Growth of the global gastrointestinal stents market is expected to be fuelled by increasing product launches
with novel technology by key players in the market. For instance, in 2013, Cook Medical Inc. received
U.S. Food and Drug Administration (FDA) for biliary stent, adding to the line of controlled-release
gastrointestinal tract. Moreover, Evolution biliary stent incorporates patency design, to prevent migration
of stent after its insertion. Furthermore, in 2012, Boston Scientific Corporation launched WallFlex, biliary
Transhepatic Stent System for the treatment of benign biliary strictures. Companies are focusing on
manufacturing stents with biodegradable material to eliminate stent removal procedures. However,
implantable products are subjected to stringent regulations, and this is expected to hinder growth of the
gastrointestinal stent market. Moreover, complication associated with gastrointestinal stent implantation is
also expected to be major factor leading to low adoption of these device.
Increasing demand for minimally invasive procedures is expected to be a major factor driving growth of
gastrointestinal stents market size. Gastrointestinal stenting is considered as minimally invasive therapy
and is increasingly gaining popularity, owing to its advantages such as low risk of infection, less recovery
time as compared to conventional open surgery procedures, and reduced hospital stay.
Download PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/1756